komisie pre monitorovanie údajov z klinického skúšania
Subject h.
komisie pre monitorovanie údajov z klinického skúšania
Subject h.
Clinical Trials Data Monitoring Committees
Entry terms
komisie pre monitorovanie údajov z klinických štúdií komisie pre monitorovanie dát z klinického skúšania výbory pre monitorovanie údajov a bezpečnosti rady pre monitorovanie údajov a bezpečnosti výbory pre monitorovanie bezpečnosti rady pre monitorovanie bezpečnosti komisie pre monitorovanie dát z klinických štúdií komisie pre monitorovanie údajov z klinických skúšok
English X references
Data and Safety Monitoring Boards Safety Monitoring Boards
Scope note in English
Committees established to review interim data and efficacy outcomes in clinical trials. The findings of these committees are used in deciding whether a trial should be continued as designed, changed, or terminated. Government regulations regarding federally-funded research involving human subjects (the "Common Rule") require (45 CFR 46.111) that research ethics committees reviewing large-scale clinical trials monitor the data collected using a mechanism such as a data monitoring committee. FDA regulations (21 CFR 50.24) require that such committees be established to monitor studies conducted in emergency settings.
See also reference (FX) in Slovak
skúšanie klinické ako téma komisie etické pre výskum projekt výskumný
See also reference (FX) in English
Clinical Trials as Topic Ethics Committees, Research Research Design
Links
(3) - ARTICLES
(3) - MeSH descriptor
(1) - ELECTRONIC RESOURCES
(1) - BOOKS
subject heading
Number of the records: 1
openseadragon
This site uses cookies to make them easier to browse. Learn more about
how we use cookies.